Keratinocyte barrier function pathways

Keratinocyte barrier function pathways represent the integrated biological processes responsible for maintaining the skin's physical and chemical integrity. The primary structural component is the cornified envelope, a resilient scaffold formed by the cross-linking of proteins such as filaggrin, loricrin, and involucrin, which is further sealed by a specialized lipid matrix of ceramides, cholesterol, and free fatty acids (Source: Kubo et al., 2012, J. Dermatol. Sci.). Additionally, tight junctions composed of claudins and occludins in the stratum granulosum provide a critical paracellular seal against water loss and environmental allergens (Source: Brandner et al., 2015, Semin. Cell Dev. Biol.). Dysfunction in these pathways is a central driver of inflammatory skin diseases like atopic dermatitis, where genetic mutations in the filaggrin (FLG) gene or cytokine-mediated suppression (via IL-4 and IL-13) lead to a 'leaky' barrier and subsequent immune activation (Source: Palmer et al., 2006, Nat. Genet.). Therapeutic intervention focuses on restoring this barrier, either through the use of Aryl hydrocarbon receptor (AhR) agonists like tapinarof, which upregulate barrier protein expression, or through biologics like dupilumab that block the inhibitory effects of Th2 cytokines on the epidermal differentiation complex (Source: Bissonnette et al., 2021, J. Am. Acad. Dermatol.). Because this term describes a collection of pathways rather than a single molecular entity, it is classified as a biological process rather than a discrete therapeutic target.

Other names

Skin barrier functionEpidermal barrier functionCornification pathwayKeratinocyte differentiation programStratum corneum barrier

Modulation of transcription factors such as the Aryl hydrocarbon receptor (AhR) to induce the expression of structural proteins like filaggrin and loricrin; inhibition of Th2 cytokines (IL-4, IL-13) to prevent the downregulation of barrier proteins and tight junction components; and activation of PPAR receptors to enhance epidermal lipid synthesis (Source: Furue et al., 2014, J. Dermatol. Sci.; Guttman-Yassky et al., 2019, J. Allergy Clin. Immunol.).